Literature DB >> 24212258

Narrowing the gap: effects of intervention on developmental trajectories in autism.

Lars Klintwall1, Sigmund Eldevik2, Svein Eikeseth2.   

Abstract

Although still a matter of some debate, there is a growing body of research supporting Early and Intensive Behavioral Intervention as the intervention of choice for children with autism. Learning rate is an alternative to change in standard scores as an outcome measure in studies of early intervention. Learning rates can be displayed graphically as developmental trajectories, which are easy to understand and avoid some of the counter-intuitive properties of changes in standard scores. The data used in this analysis were from 453 children with autism, previously described by Eldevik et al. Children receiving Early and Intensive Behavioral Intervention exhibited significantly steeper developmental trajectories than children in the control group, in both intelligence and adaptive behaviors. However, there was a considerable variability in individual learning rates within the group receiving Early and Intensive Behavioral Intervention. This variability could partly be explained by the intensity of the treatment, partly by children's intake intelligence quotient age-equivalents. Age at intake did not co-vary with learning rate.
© The Author(s) 2013.

Entities:  

Keywords:  Early and Intensive Behavioral Intervention; autism; behavioral intervention; developmental trajectories; early intervention

Mesh:

Year:  2013        PMID: 24212258     DOI: 10.1177/1362361313510067

Source DB:  PubMed          Journal:  Autism        ISSN: 1362-3613


  22 in total

1.  Interest level in 2-year-olds with autism spectrum disorder predicts rate of verbal, nonverbal, and adaptive skill acquisition.

Authors:  Lars Klintwall; Suzanne Macari; Svein Eikeseth; Katarzyna Chawarska
Journal:  Autism       Date:  2014-11-14

2.  Education for Children With ASD in South Korea: A Case Study.

Authors:  Hyesuk Lee Park; Lin Du; Jinhyeok Choi
Journal:  Behav Anal Pract       Date:  2020-08-17

3.  Integrating the Early Start Denver Model into Israeli community autism spectrum disorder preschools: Effectiveness and treatment response predictors.

Authors:  Yana Sinai-Gavrilov; Tali Gev; Irit Mor-Snir; Giacomo Vivanti; Ofer Golan
Journal:  Autism       Date:  2020-07-14

Review 4.  Genetic basis of human congenital anomalies of the kidney and urinary tract.

Authors:  Simone Sanna-Cherchi; Rik Westland; Gian Marco Ghiggeri; Ali G Gharavi
Journal:  J Clin Invest       Date:  2018-01-02       Impact factor: 14.808

5.  Policy and Practice Barriers to Early Identification of Autism Spectrum Disorder in the California Early Intervention System.

Authors:  Marian E Williams; Eliza K Harley; Irina Quebles; Marie Kanne Poulsen
Journal:  J Autism Dev Disord       Date:  2021-01-01

6.  Brain circuitry, behavior, and cognition: A randomized placebo-controlled trial of donepezil in fragile X syndrome.

Authors:  Jennifer L Bruno; Sm Hadi Hosseini; Amy A Lightbody; Mai K Manchanda; Allan L Reiss
Journal:  J Psychopharmacol       Date:  2019-07-02       Impact factor: 4.153

7.  Autism Spectrum Disorders and Low Mental Age: Diagnostic Stability and Developmental Outcomes in Early Childhood.

Authors:  Alexander J Hinnebusch; Lauren E Miller; Deborah A Fein
Journal:  J Autism Dev Disord       Date:  2017-12

8.  Parents' Concerns as They Relate to Their Child's Development and Later Diagnosis of Autism Spectrum Disorder.

Authors:  Megan Richards; Jana Mossey; Diana L Robins
Journal:  J Dev Behav Pediatr       Date:  2016-09       Impact factor: 2.225

9.  Indicators of intellectual disabilities in young children with autism spectrum disorders.

Authors:  Mélina Rivard; Amélie Terroux; Céline Mercier; Claudel Parent-Boursier
Journal:  J Autism Dev Disord       Date:  2015-01

10.  Evaluation of a low-intensity version of the early start Denver model with four preschool-aged boys with autism spectrum disorder.

Authors:  Hannah Waddington; Larah van der Meer; Jeff Sigafoos; Emily Ogilvie
Journal:  Int J Dev Disabil       Date:  2019-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.